{"id":"https://openalex.org/A5045529581","orcid":"https://orcid.org/0009-0006-5375-9717","observed_orcids":["https://orcid.org/0009-0006-5375-9717"],"display_name":"Lena Lemke","raw_author_names":["L. Lemke","Lemke, Lena","Lena Lemke"],"full_name":"Lemke, Lena","works_count":18,"cited_by_count":102,"summary_stats":{"2yr_mean_citedness":2.0,"h_index":6,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5045529581","orcid":"https://orcid.org/0009-0006-5375-9717","observed_orcids":["https://orcid.org/0009-0006-5375-9717"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210090224","ror":"https://ror.org/00abnnq69","display_name":"Hexal (Germany)","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]},"years":[2025,2024,2023,2022,2021,2019]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":17,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":12,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","count":7,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":5,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","count":3,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":0.0001992,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":3.48e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","value":2.12e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":2.01e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","value":1.53e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","score":0.9696583151817322},{"id":"2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","score":0.9458000063896179},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9426783323287964},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6392999887466431},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.5975782871246338}],"counts_by_year":[{"year":2019,"works_count":4,"oa_works_count":3,"cited_by_count":4},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2021,"works_count":2,"oa_works_count":1,"cited_by_count":11},{"year":2022,"works_count":3,"oa_works_count":2,"cited_by_count":14},{"year":2023,"works_count":3,"oa_works_count":2,"cited_by_count":12},{"year":2024,"works_count":3,"oa_works_count":3,"cited_by_count":17},{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":28},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":12}],"display_name_alternatives":["L. Lemke","Lemke, Lena","Lena Lemke"],"block_key":"l lemke","works_api_url":"https://api.openalex.org/works?filter=author.id:A5045529581","awards_count":0,"updated_date":"2026-11-07T12:08:38","created_date":"2019-02-21T00:00:00"}